Impairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma

BACKGROUND: The incidence of long-term survival in glioblastoma (GBM), i.e., >3 years, ranges from 3% to 5%. Although extensive research is performed in novel therapies for prolonging survival, there is a scarcity of research focusing on the impact of tumor and treatment on cognitive, psychologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Solanki, Chirag, Sadana, Divya, Arimappamagan, Arivazhagan, Rao, K.V.L.N., Rajeswaran, Jamuna, Subbakrishna, D. K., Santosh, Vani, Pandey, Paritosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402490/
https://www.ncbi.nlm.nih.gov/pubmed/28479798
http://dx.doi.org/10.4103/0976-3147.203829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402490/
https://www.ncbi.nlm.nih.gov/pubmed/28479798
http://dx.doi.org/10.4103/0976-3147.203829

Ejemplares similares